Integrated Diagnostics (OTCMKTS:IDGXF) Stock Price Down 2.6% – What’s Next?

Integrated Diagnostics Holdings plc (OTCMKTS:IDGXFGet Free Report)’s share price fell 2.6% on Wednesday . The stock traded as low as $0.68 and last traded at $0.68. 500 shares were traded during trading, a decline of 78% from the average session volume of 2,318 shares. The stock had previously closed at $0.6983.

Integrated Diagnostics Stock Down 2.6%

The company’s 50 day simple moving average is $0.65 and its 200 day simple moving average is $0.50.

Integrated Diagnostics Company Profile

(Get Free Report)

Integrated Diagnostics Holdings PSC (OTCMKTS: IDGXF) is a leading provider of diagnostic services in the United Arab Emirates and the broader Gulf Cooperation Council (GCC) region. Headquartered in Abu Dhabi, the company operates an extensive network of pathology laboratories and radiology facilities, offering a comprehensive suite of clinical testing and medical imaging services. Its offerings span routine laboratory tests, advanced molecular diagnostics, histopathology, and a range of radiological modalities such as MRI, CT, ultrasound, and X-ray.

Since its founding in 1993, Integrated Diagnostics has expanded its footprint across the UAE, with patient service centers and lab collection points in Abu Dhabi, Dubai, and the Northern Emirates.

See Also

Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.